Manila Bulletin
Sinovac use eyed in ‘specific sector’ during PH clinical trials --- DOH
The Food and Drug Administration (FDA) has approved Sinovac Biotech's application to conduct clinical trials for its COVID-19 vaccine in the Philippines.
The clinical trials for Sinovac's COVID-19 vaccine will still push through even though it is already applying for an emergency use authorization in the Philippines.
The vaccine will be used in a "specific sector" during the conduct of its clinical trials in the Philippines to assess its effects on Asians and this specific group of population.
The Department of Health (DOH) aims to gather data from these trials to see the vaccine's efficacy among the target demographic.
Previously, the Vaccine Expert Panel (VEP) under the Department of Science and Technology (DOST) had cleared Sinovac for clinical trials in October.
Despite concerns about potential overpricing and government preference, Health Secretary Francisco Duque III announced that the Philippines has secured 25 million doses of the Sinovac vaccine, with an initial delivery of 50,000 doses expected in February.
Aside from Sinovac, the FDA has also approved the clinical trials of China's Clover Pharmaceuticals and Belgium-based Janssen Pharmaceuticals.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Chinese pharmaceutical company Sinovac has submitted an application for emergency use authorization (EUA) to the Philippine Food and Drug Administration (FDA).
Read more →
The local distributor of Sinopharm vaccines in the Philippines, MKG Universal Trading Corporation, is investigating how approximately 20 vials of unregistered Sinopharm COVID-19 vaccines arrived in the country.
Read more →
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to the Pfizer-BioNTech COVID-19 vaccine, making it the first to receive such approval in the country.
+2
Read more →
Indian vaccine manufacturer Bharat BioTech has submitted an application to the Philippine Food and Drug Administration (FDA) for an emergency use authorization (EUA) for its COVID-19 vaccine, Covaxin.
Read more →
A vaccine expert panel member advised that President Rodrigo Duterte should receive a COVID-19 vaccine that has already completed Phase III clinical trials, specifically mentioning Pfizer, Moderna, and AstraZeneca.
Read more →